Arthur S. Centeno

Granulocyte Macrophage Colony-Stimulating Factor–Secreting Allogeneic Cellular Immunotherapy for Hormone-Refractory Prostate Cancer

Eric J. Small, Natalie Sacks, John Nemunaitis et al. · Clinical Cancer Research · 2007 · 235 citations

Phase 1/2 dose‐escalation study of a GM‐CSF‐secreting, allogeneic, cellular immunotherapy for metastatic hormone‐refractory prostate cancer

Celestia S. Higano, John M. Corman, David C. Smith et al. · Cancer · 2008 · 212 citations · Full text

Similar frequency of testosterone surge after repeat injections of goserelin (Zoladex) 3.6 mg and 10.8 mg: Results of a randomized open-label trial

Norman R. Zinner, Mohamed Bidair, Arthur S. Centeno et al. · Urology · 2004 · 59 citations

Urology, Gynecology, Repeat Injections +5

Renal cell carcinoma metastatic to the gallbladder or prostate: Two case reports

D. H. King, Arthur S. Centeno, Victor A. Saldivar et al. · Urology · 1995 · 44 citations

Urology, Genitourinary Cancer, Biliary Cancer +5

An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists

Michael O. Koch, Christopher P. Steidle, Stanley A. Brosman et al. · Urology · 2003 · 42 citations

Urology, Oncology, Symptomatic Prostate Cancer +7